Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders
Molecular Therapy Advances
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26002065?dgcid=rss_sd_all
Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26002065?dgcid=rss_sd_all
“Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders.” Molecular Therapy Advances.
@article{article59003,
title = {Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26002065?dgcid=rss_sd_all}
}